These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2591993)

  • 1. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone).
    Cox D; O'Kennedy R; Thornes RD
    Hum Toxicol; 1989 Nov; 8(6):501-6. PubMed ID: 2591993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-effects of coumarin.
    Morrison L; Welsby PD
    Postgrad Med J; 1995 Nov; 71(841):701. PubMed ID: 7494781
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats.
    Murat Bilgin H; Atmaca M; Deniz Obay B; Ozekinci S; Taşdemir E; Ketani A
    Exp Toxicol Pathol; 2011 May; 63(4):325-30. PubMed ID: 20207117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of coumarin hepatotoxicity.
    Casley-Smith JR; Casley-Smith JR
    Med J Aust; 1995 Apr; 162(7):391. PubMed ID: 7715532
    [No Abstract]   [Full Text] [Related]  

  • 6. Coumarin-Induced Hepatotoxicity: A Narrative Review.
    Pitaro M; Croce N; Gallo V; Arienzo A; Salvatore G; Antonini G
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic dysfunction after renal transplantation in children.
    Malekzadeh MH; Grushkin CM; Wright HT; Fine RN
    J Pediatr; 1972 Aug; 81(2):279-85. PubMed ID: 4339534
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of liver disease in patients taking salicylates for arthropathy.
    Carneskog J; Florath-Ahlmen M; Olsson R
    Hepatogastroenterology; 1980 Oct; 27(5):361-4. PubMed ID: 7203370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute cytolytic hepatitis caused by coumarin. 2 cases].
    Koch S; Beurton I; Bresson-Hadni S; Monnot B; Hrusovsky S; Becker MC; Vanlemmens C; Carbillet JP; Miguet JP
    Gastroenterol Clin Biol; 1997; 21(3):223-5. PubMed ID: 9161499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
    Siramolpiwat S; Sakonlaya D
    Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.
    Shantakumar S; Landis S; Lawton A; Hunt CM
    Regul Toxicol Pharmacol; 2016 Jun; 77():257-62. PubMed ID: 27025923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.
    Tsung I; Dolan R; Lao CD; Fecher L; Riggenbach K; Yeboah-Korang A; Fontana RJ
    Aliment Pharmacol Ther; 2019 Oct; 50(7):800-808. PubMed ID: 31309615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coumarin-induced hepatotoxicity.
    Loprinzi CL; Sloan J; Kugler J
    J Clin Oncol; 1997 Sep; 15(9):3167-8. PubMed ID: 9294482
    [No Abstract]   [Full Text] [Related]  

  • 15. Lympidem (a coumarin derivative) induced reversible hepatotoxicity in an adult Sri Lankan.
    Satarasinghe RL; Jayawardana MA
    Drug Metabol Drug Interact; 2009; 24(1):89-94. PubMed ID: 19354003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a benzopyrone compound on liver function. Short communication (author's transl)].
    Cerlek S
    Arzneimittelforschung; 1977; 27(3):611-2. PubMed ID: 577428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Favorable development of parenchymal liver diseases].
    Hofstetter JR
    Schweiz Med Wochenschr; 1968 Feb; 98(5):140-3. PubMed ID: 4173850
    [No Abstract]   [Full Text] [Related]  

  • 18. Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin.
    Adam BS; Pentz R; Siegers CP; Strubelt O; Tegtmeier M
    Phytomedicine; 2005 Jan; 12(1-2):52-61. PubMed ID: 15693708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of liver damage following coumarin medication].
    Kreiter H; Fink U
    Med Klin; 1967 Jan; 62(1):12-5. PubMed ID: 6032217
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical correlations in alcoholic patients without manifest cirrhosis.
    Bordalo O; Batista A; Geraldes J; Neto F; Mascarenhas F; Leitao N; Noronha M; Lamy J; Silva PE
    Am J Gastroenterol; 1974 May; 61(5):371-8. PubMed ID: 4835934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.